Vitamin K epoxide reductase (VKORCI) genetic polymorphism is associated to oral anticoagulant overdose

被引：21

作者：

Quteineh, L

Verstuyft, C

Descot, C

Dubert, L

Robert, A

Jaillon, P

Becquemont, L

机构：

[1] Univ Paris 06, Dept Pharmacol, St Antoine Univ Med, Assistance Publ Hop Paris, Paris, France

[2] Univ Paris Sud, Assistance Publ Hop Paris, Bicetre Univ Hosp, Dept Pharmacol, F-94275 Le Kremlin Bicetre, France

[3] Bicetre Univ Hosp, Climat Res Unit, Assistance Publ Hop Paris, Le Kremlin Bicetre, France

[4] St Antoine Univ Hosp, Assistance Publ Hop Paris, Dept Immunol & Hematol, Paris, France

来源：

THROMBOSIS AND HAEMOSTASIS | 2005年 / 94卷 / 03期

关键词：

D O I：

10.1160/TH05-03-0690

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：690 / 691

页数：2

共 10 条

[1] Cytochrome P4502C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity [J].

Bodin, L ;

Verstuyft, C ;

Tregouet, DA ;

Robert, A ;

Dubert, L ;

Funck-Brentano, C ;

Jaillon, P ;

Beaune, P ;

Laurent-Puig, P ;

Becquemont, L ;

Loriot, MA .

BLOOD, 2005, 106 (01) :135-140

[2] A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin [J].

D'Andrea, G ;

D'Ambrosio, RL ;

Di Perna, P ;

Chetta, M ;

Santacroce, R ;

Brancaccio, V ;

Grandone, E ;

Margaglione, M .

BLOOD, 2005, 105 (02) :645-649

[3] Pharmacogenetics of oral anticoagulants [J].

Daly, AK ;

King, BP .

PHARMACOGENETICS, 2003, 13 (05) :247-252

[4] ANTICOAGULANT-RELATED BLEEDING - CLINICAL EPIDEMIOLOGY, PREDICTION, AND PREVENTION [J].

LANDEFELD, CS ;

BEYTH, RJ .

AMERICAN JOURNAL OF MEDICINE, 1993, 95 (03) :315-328

[5] Identification of the gene for vitamin K epoxide reductase [J].

Li, T ;

Chang, CY ;

Jin, DY ;

Lin, PJ ;

Khvorova, A ;

Stafford, DW .

NATURE, 2004, 427 (6974) :541-544

[6] Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose [J].

Rieder, MJ ;

Reiner, AP ;

Gage, BF ;

Nickerson, DA ;

Eby, CS ;

McLeod, HL ;

Blough, DK ;

Thummel, KE ;

Veenstra, DL ;

Rettie, AE .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) :2285-2293

[7] Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 [J].

Rost, S ;

Fregin, A ;

Ivaskevicius, V ;

Conzelmann, E ;

Hörtnagel, K ;

Pelz, HJ ;

Lappegard, K ;

Seifried, E ;

Scharrer, I ;

Tuddenham, EGD ;

Müller, CR ;

Strom, TM ;

Oldenburg, J .

NATURE, 2004, 427 (6974) :537-541

[8] Medicine: K is for koagulation [J].

Sadler, JE .

NATURE, 2004, 427 (6974) :493-494

[9] Genetic and environmental risk factors for oral anticoagulant overdose [J].

Verstuyft, C ;

Robert, A ;

Morin, S ;

Loriot, MA ;

Flahault, A ;

Beaune, P ;

Funck-Brentano, C ;

Jaillon, P ;

Becquemont, L .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (11) :739-745

[10] A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity [J].

Yuan, HY ;

Chen, JJ ;

Lee, MTM ;

Wung, JC ;

Chen, YF ;

Charng, MJ ;

Lu, MJ ;

Hung, CR ;

Wei, CY ;

Chen, CH ;

Wu, JY ;

Chen, YT .

HUMAN MOLECULAR GENETICS, 2005, 14 (13) :1745-1751

← 1 →